The New York TimesAug 19, 2020 14:24:20 IST
To the immune system, not all germs are equally memorable. But our bodys cells seem to be seriously studying up on the coronavirus.
Scientists who have been monitoring immune responses to the virus are now starting to see encouraging signs of strong, lasting immunity, even in people who developed only mild symptoms of COVID-19, a flurry of new studies suggests. Disease-fighting antibodies, as well as immune cells, called B cells and T cells that are capable of recognizing the virus, appear to persist months after infections have resolved an encouraging echo of the bodys enduring response to other viruses.
Things are really working as theyre supposed to, said Deepta Bhattacharya, an immunologist at the University of Arizona and an author on one of the new studies, which has not yet been peer-reviewed.
Although researchers cannot forecast how long these immune responses will last, many experts consider the data a welcome indication that the bodys most studious cells are doing their job and will have a good chance of fending off the coronavirus, faster and more fervently than before, if exposed to it again.
This is exactly what you would hope for, said Marion Pepper, an immunologist at the University of Washington and an author on another of the new studies, which is currently under review at the journal Nature. All the pieces are there to have a totally protective immune response.
Protection against reinfection cannot be fully confirmed until there is proof that most people who encounter the virus a second time are actually able to keep it at bay, Pepper said. But the findings could help quell recent concerns over the viruss ability to dupe the immune system into amnesia, leaving people vulnerable to repeat bouts of disease.
Researchers have yet to find unambiguous evidence that coronavirus reinfections are occurring, especially within the few months that the virus has been rippling through the human population. The prospect of immune memory helps to explain that, Pepper said.
Face shields and masks for sale in New York on March 23, 2020. The clear plastic guards may be easier to wear, disinfect and reuse than cloth or surgical face coverings, although they dont entirely replace the need for masks. (Marian Carrasquero/The New York Times)
In discussions about immune responses to the coronavirus, much of the conversation has focused on antibodies Y-shaped proteins that can latch onto the surfaces of pathogens and block them from infecting cells. But antibodies represent just one wing of a complex and coordinated squadron of immune soldiers, each with its own unique modes of attack. Viruses that have already invaded cells, for instance, are cloaked from antibodies but are still vulnerable to killer T cells, which force infected cells to self-destruct. Another set of T cells, nicknamed helpers, can coax B cells to mature into antibody-making machines.
(Yet another sector of the immune system assails pathogens within minutes of their arrival while sending out signals called cytokines to mobilize forces from elsewhere in the body. Some evidence suggests that severe cases of COVID-19 may stem from this early process going awry.)
Antibodies also come with an expiration date: Because they are inanimate proteins and not living cells, they cant replenish themselves, and so disappear from the blood just weeks or months after they are produced. Hoards of antibodies appear shortly after a virus has breached the bodys barriers, then wane as the threat dissipates. Most of the B cells that produce these early antibodies die off as well.
But even when not under siege, the body retains a battalion of longer-lived B cells that can churn out virus-fighting antibodies en masse, should they prove useful again. Some patrol the bloodstream, waiting to be triggered anew; others retreat into the bone marrow, generating small amounts of antibodies that are detectable years, sometimes decades, after an infection is over. Several studies, including those led by Bhattacharya and Pepper, have found antibodies capable of incapacitating the coronavirus lingering at low levels in the blood months after people have recovered from COVID-19.
The antibodies decline, but they settle in what looks like a stable nadir, which is observable about three months after symptoms start, Bhattacharya said. The response looks perfectly durable.
Seeing antibodies this long after infection is a strong indication that B cells are still chugging away in the bone marrow, Pepper said. She and her team were also able to pluck B cells that recognize the coronavirus from the blood of people who have recovered from mild cases of COVID-19 and grow them in the lab.
Multiple studies, including one published Friday in the journal Cell, have also managed to isolate coronavirus-attacking T cells from the blood of recovered individuals long after symptoms have disappeared. When provoked with bits of the coronavirus in the lab, these T cells pumped out virus-fighting signals, and cloned themselves into fresh armies ready to confront a familiar foe. Some reports have noted that analyses of T cells could give researchers a glimpse into the immune response to the coronavirus, even in patients whose antibody levels have declined to a point where they are difficult to detect.
This is very promising, said Smita Iyer, an immunologist at the University of California, Davis, who is studying immune responses to the coronavirus in rhesus macaques but was not involved in the new studies. This calls for some optimism about herd immunity, and potentially a vaccine.
Notably, several of the new studies are finding these powerful responses in people who did not develop severe cases of COVID-19, Iyer added. Some researchers have worried that infections that take a smaller toll on the body are less memorable to the immune systems studious cells, which may prefer to invest their resources in more serious assaults. In some cases, the body could even jettison the viruses so quickly that it fails to catalog them. This paper suggests this is not true, Iyer said. You can still get durable immunity without suffering the consequences of infection.
A resident wears a mask to curb the spread of the coronavirus, while browsing meat products at a Beijing supermarket on 15 June 2020. The capital is bracing for a resurgence of the coronavirus after more than 100 new cases were reported in recent days in the city, which hadnt seen a case of local transmission in more than a month. Image: AP
What has been observed in people who fought off mild cases of COVID-19 might not hold true for hospitalized patients, whose bodies struggle to marshal a balanced immune response to the virus, or those who were infected but had no symptoms at all. Research groups around the world are continuing to study the entire range of responses. But the vast majority of the cases are these mild infections, said Jason Netland, an immunologist at the University of Washington and an author on the paper under review at Nature. If those people are going to be protected, thats still good.
This new spate of studies could also further assuage fears about how and when the pandemic will end. On Friday, updated guidance released by the Centers for Disease Control and Prevention was misinterpreted by several news reports that suggested immunity against the coronavirus might last only a few months. Experts quickly responded, noting the dangers of propagating such statements and pointing to the wealth of evidence that people who previously had the virus are probably at least partly protected from reinfection for at least three months, if not much longer.
Considered with other recent reports, the new data reinforce the idea that, Yes, you do develop immunity to this virus, and good immunity to this virus, said Dr. Eun-Hyung Lee, an immunologist at Emory University who was not involved in the studies. Thats the message we want to get out there.
Some illnesses, like the flu, can plague populations repeatedly. But that is at least partly attributable to the high mutation rates of influenza viruses, which can quickly make the pathogens unrecognizable to the immune system. Coronaviruses, in contrast, tend to change their appearance less readily from year to year.
Still, much remains unknown. Although these studies hint at the potential for protectiveness, they do not demonstrate protection in action, said Cheong-Hee Chang, an immunologist at the University of Michigan who was not involved in the new studies. Its hard to predict whats going to happen, Chang said. Humans are so heterogeneous. There are so many factors coming into play.
Research in animals could help fill a few gaps. Small studies have shown that one bout of the coronavirus seems to protect rhesus macaques from contracting it again.
But tracking long-term human responses will take time, Pepper said. Good immune memory, she added, requires molecules and cells to be abundant, effective and durable and scientists cannot yet say that all three conditions have been definitively met.
As peoples bodies settle into their post-coronavirus state, were just now hitting the point of relevance to take the long view on immunity, Bhattacharya said. Things may change a few months or years down the line. Or they may not.
Theres no shortcuts here, Bhattacharya said. We just have to follow it out.
Katherine J. Wuc.2020 The New York Times Company
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
- Arizona Oncology Cancer Center working with NexCore Group on new cancer treatment center - Yahoo Finance - October 13th, 2022
- Senate Passes 'Inflation Reduction Act' Which Will Likely Make Inflation Worse - Reason - August 14th, 2022
- Reds prospect rankings will shift after trade deadline acquisition of 10 players - The Athletic - August 5th, 2022
- Stem Cell Therapy Pros and Cons - Arizona Pain and Spine Institute - July 11th, 2022
- Bone Anatomy | Ask A Biologist - Arizona State University - July 11th, 2022
- No, "Top Gun" isn't an anti-woke success story, but rather a tribute to aging Tom Cruise and balls - Salon - June 4th, 2022
- Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit - Lewiston Sun Journal - June 4th, 2022
- BioEclipse Therapeutics Awarded Almost $8 Million Grant by California Institute for Regenerative Medicine (CIRM) to Fund Ongoing Phase 1 CRX100 Cancer... - May 2nd, 2022
- Right to Try 2.0: Ahwatukee family pushes for proposed law after getting medical treatment abroad - FOX 10 News Phoenix - April 6th, 2022
- Inside the real life Noahs Ark designed to save mankind after the apocalypse with a back up vault on t... - The US Sun - January 5th, 2022
- Human Embryonic Stem Cells - Arizona State University - November 22nd, 2021
- Mindy Kaling's 'The Sex Lives of College Girls' Is a Spot-On Depiction of College - Glamour - November 22nd, 2021
- Bridging the gap between online and on campus - ASU Now - November 22nd, 2021
- Bacterial Infections Linked with Unapproved Stem Cell Treatments - Contagionlive.com - October 28th, 2021
- ASU professor researches origins of Alzheimers to find a cure - Eight, Arizona PBS - October 16th, 2021
- City of Hope to Accelerate Blood Cancer Research Through a Transformational Gift from Leukemia Survivor James Belardi and His Wife Leslie Belardi -... - October 5th, 2021
- Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy... - August 18th, 2021
- Jim McMahon broke his neck playing for Vikings, and found out about it 17 years later - TwinCities.com-Pioneer Press - December 23rd, 2020
- Want to Know Where The Best Fall Colors Are in Your Area? Check Out This Interactive US Map - Good News Network - October 5th, 2020
- 'Were not your slaves': Alternative health providers bristle at warning letters about their coronavirus treatments - USA TODAY - September 4th, 2020
- Neogene precipitation, vegetation, and elevation history of the Central Andean Plateau - Science Advances - September 4th, 2020
- Research Roundup: Lasting Immunity to COVID-19 and More - BioSpace - August 21st, 2020
- What in the world is 'Project Carpaccio' and which Israeli company is doing business in Abu Dhabi? - CTech - August 21st, 2020
- Viruses have big impacts on ecology and evolution as well as human health - The Economist - August 21st, 2020
- Encouraging News About Coronavirus Immunity | In the Pipeline - Science Magazine - August 21st, 2020
- Studies show positive signs of strong, lasting Covid-19 immunity - The Irish Times - August 21st, 2020
- Coronavirus vaccine will take time, so researchers are hunting for and finding promising new COVID-19 tre - OregonLive - April 6th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 24th, 2020
- Unlocking The Secrets Of DNA Help Researchers Understand How to Slow Aging - YouAreUNLTD - January 9th, 2020
- An ESPN reporter was diagnosed with HLH just before he died at age 34. What is it? - ABC15 Arizona - January 2nd, 2020
- 2020s visions: We'll get flying cars just before becoming software-based people - CNET - December 19th, 2019
- Man fights $4,600 surgery bill he was told insurance would cover - KGUN - December 8th, 2019
- Professor Recognized For Cardiac Regeneration Research - WPI News - December 8th, 2019
- Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast - Yahoo Finance - October 19th, 2019
- Bone marrow recipient comes face-to-face with CT donor for the first time - WTNH.com - October 19th, 2019
- Positive Study Results of Phase IIa Clinical Trial Using Intravenous Administration of Mesenchymal Stem Cells for Ischemic Stroke Published in... - October 1st, 2019
- Stem Cell Education Center - Stem Cell Treatment | Arizona ... - September 14th, 2019
- Stem Cell Therapy In Scottsdale Arizona | Regenerative ... - September 12th, 2019
- Stem Cell Therapy | Board Certified Orthopedic Surgeon ... - March 16th, 2019
- Stem Cell Lake Havasu City Arizona 86406 - March 8th, 2019
- Stem Cell Therapy for Cancer | Arizona Pain and Spine ... - December 18th, 2018
- Stem Cells | Arizona Pain Specialists - Scottsdale ... - December 11th, 2018
- Arizona Pain Regenerative Institute - Arizona Pain Specialists - December 5th, 2018
- Stem Cell Therapy Phoenix Arizona | Desert Health Specialists - December 4th, 2018
- Southwest Spine and Sports - Pain Management Doctor Arizona - September 24th, 2018
- Celebration Stem Cell Centre - A private umbilical cord ... - August 12th, 2018
- Bone marrow transplant - Mayo Clinic - July 15th, 2018
- About Dr. Nabil Dib - June 27th, 2018
- Around the world - Bend Bulletin - August 30th, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - KNAU Arizona Public Radio - August 30th, 2017
- BrainStorm Supports Commitment to ALS Patient Community with ... - Markets Insider - August 8th, 2017
- ASU grad students' lab skills help earn funding for cutting-edge biomedical research - Arizona State University - August 8th, 2017
- Will putting leeches on his face help this blind man see? - USA TODAY - August 8th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study ... - Arizona Daily Star - August 8th, 2017
- 'Soft' side of bioengineering poised to make big impacts - Arizona State University - August 4th, 2017
- Tackling hard-to-treat cancers from every angle - Medical Xpress - June 21st, 2017
- ALS Research Forum | To Evaluate Stem Cell Therapies, Think ... - ALS Research Forum - June 20th, 2017
- New book by ASU researcher explores cancer's pervasive mysteries - Arizona State University - June 18th, 2017
- Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents - Reason (blog) - June 15th, 2017
- Can We Cheat Death? US Firm Aims To Resurrect Brain-Dead People Using Stem Cells - International Business Times - June 11th, 2017
- The three cancers Jews need to worry about most and how to reduce the risks - Jewish Post - June 11th, 2017
- Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature - satPRnews (press release) - May 31st, 2017
- 6 Arizona young women are taking on the STEM gender gap - AZCentral.com - May 28th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Texas Tribune - May 26th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Bryan-College Station Eagle - May 24th, 2017
- ASU engineers envision 'guiding' body's cells to help improve health - Arizona State University - May 19th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol | Sun Life ... - Sahuarita Sun (subscription) - May 19th, 2017
- Derek McCartney Named To Lott IMPACT Trophy Watch List - KKTV 11 News - May 18th, 2017
- Tucson Tech: University of Arizona startup advances living heart patch - Arizona Daily Star - May 15th, 2017
- Scientists uncover root of graying, thinning hair - Arizona Daily Star - May 15th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol - Green Valley News - May 15th, 2017
- 7-year-old Hollis spread joy around U.S. After losing him to rare brain tumor, parents turn to finding cure - AZCentral.com - May 1st, 2017
- Young minds meet new technology at STEM-focused after-school program - USC News - April 19th, 2017
- Applications for Tissue Culture in Cannabis Growing: Part 1 - Cannabis Industry Journal (blog) - April 14th, 2017
- Yankees: James Kaprielian Getting Tommy John Surgery Out of the Way - Yanks Go Yard - April 14th, 2017
- Can Stem Cell 'Patch' Help Heart Failure? - Arizona Daily Star - April 9th, 2017
- Angels' focus is on defense - Reading Eagle - April 2nd, 2017
- Some restoration drama at the Big A as Dodgers top Angels, 3-1 - Los Angeles Times - April 1st, 2017
- Robert Clayton Robbins Top Choice for UA President - Arizona Public Media - March 10th, 2017
- R. William Funk Lands New Leader for University of Arizona - Hunt Scanlon Media (press release) - March 9th, 2017